American Society of Hematology

Figure 4.

Published dabigatran (DIVERSITY-phase 2b/3) dosing strategy according to formulation (VTE treatment).20 Dosing regimen using dabigatran capsules (A), dosing regimen using pellets (B), and dosing regimen using oral liquid formulation (OLF) (C). Adapted from Halton et al20 with permission from Elsevier.

Published dabigatran (DIVERSITY-phase 2b/3) dosing strategy according to formulation (VTE treatment).²⁰ Dosing regimen using dabigatran capsules (A), dosing regimen using pellets (B), and dosing regimen using oral liquid formulation (OLF) (C). Adapted from Halton et al²⁰ with permission from Elsevier.

This Feature Is Available To Subscribers Only